Blog
Keep up to date with the latest news from Instem.
Instem Announces Major UK Headquarters Refurbishment
Modernised Headquarters Underscores Instem’s Commitment to Innovation, Customer Excellence and the Local Region
Instem Relaunches the d-wise Brand to Support the Clinical Research Community
We are excited to announce the revival of the d-wise brand to represent Instem’s Clinical Trial Analytics and Transparency offerings. This movement returns our clinical portfolio to its roots while reinforcing our dedication to supporting...
Instem Unveils New Global Headquarters in Boston, MA
A Bold Step Reflecting Customer Obsession, Strategic Growth, and a New Era for Instem
Unifying Acquisitions Under One Instem Brand
A strategic evolution that will help you move faster, make more informed decisions, and deliver greater value through your research.
Instem achieves a major milestone, acquires all shares of Xybion from Banerjee Group LLC controlled by Dr. Pradip K. Banerjee
Instem has completed its acquisition of Xybion Digital, creator of the Pristima™ preclinical study management platform.
Instem Announces Acquisition of RockStep Solutions, Inc.
Instem Strengthens Preclinical Capabilities with RockStep Acquisition and Climb™ Integration
Instem Moves into New Sustainable, Client-Centric Office at Smartworks 43EQ, Pune, India
Instem is pleased to announce the opening of our new office in Balewadi, Pune, India.
Instem and VICT3R: Pioneering Ethical Innovation in Toxicology Studies
Instem is a contributing partner in the VICT3R Consortium, a collaborative initiative exploring the use of Virtual Control Groups (VCGs) in toxicology studies.
Instem Announces Acquisition of Strong Tower Solutions, Strengthening its Clinical SCE Solutions
Strong Tower Solutions is now a part of Instem
